Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.

PHASE4TerminatedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

March 16, 2021

Study Completion Date

March 16, 2021

Conditions
Cataract Surgery
Interventions
COMBINATION_PRODUCT

Dropless Therapy

The Dropless will be injected, as a single administration, into the vitreous cavity during the cataract surgery.

DRUG

Usual Care

In order to reflect real-world clinical practice, the choice of topical ophthalmic medications as well as dosage, posology, and duration of treatment will be left to the discretion of the treating ophthalmologist.

Trial Locations (2)

H1T 2M4

CIUSSS de l'Est-de-l'Île-de-Montréal (Hôpital Maisonneuve-Rosemont), Montreal

H4A 3J1

McGill Academic Eye Center, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Advance Dosage Forms, Inc.

INDUSTRY

collaborator

Imprimis Pharmaceuticals, Inc.

INDUSTRY

lead

PeriPharm

OTHER